ZA201504060B - Ultra low density pulmonary powders - Google Patents

Ultra low density pulmonary powders

Info

Publication number
ZA201504060B
ZA201504060B ZA2015/04060A ZA201504060A ZA201504060B ZA 201504060 B ZA201504060 B ZA 201504060B ZA 2015/04060 A ZA2015/04060 A ZA 2015/04060A ZA 201504060 A ZA201504060 A ZA 201504060A ZA 201504060 B ZA201504060 B ZA 201504060B
Authority
ZA
South Africa
Prior art keywords
low density
ultra low
powders
pulmonary powders
density pulmonary
Prior art date
Application number
ZA2015/04060A
Other languages
English (en)
Inventor
Richard P Batycky
Michael M Lipp
Original Assignee
Civitas Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/679,245 external-priority patent/US8545878B1/en
Application filed by Civitas Therapeutics Inc filed Critical Civitas Therapeutics Inc
Publication of ZA201504060B publication Critical patent/ZA201504060B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • A61J3/074—Filling capsules; Related operations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/04—Methods of, or means for, filling the material into the containers or receptacles
    • B65B1/16—Methods of, or means for, filling the material into the containers or receptacles by pneumatic means, e.g. by suction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/20—Reducing volume of filled material
    • B65B1/26—Reducing volume of filled material by pneumatic means, e.g. suction
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B1/00—Packaging fluent solid material, e.g. powders, granular or loose fibrous material, loose masses of small articles, in individual containers or receptacles, e.g. bags, sacks, boxes, cartons, cans, or jars
    • B65B1/30—Devices or methods for controlling or determining the quantity or quality or the material fed or filled
    • B65B1/36—Devices or methods for controlling or determining the quantity or quality or the material fed or filled by volumetric devices or methods
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B63/00—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged
    • B65B63/02—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles
    • B65B63/028—Auxiliary devices, not otherwise provided for, for operating on articles or materials to be packaged for compressing or compacting articles or materials prior to wrapping or insertion in containers or receptacles by pneumatic means

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Mechanical Engineering (AREA)
  • Pulmonology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Quality & Reliability (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Basic Packing Technique (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
ZA2015/04060A 2012-11-09 2015-06-05 Ultra low density pulmonary powders ZA201504060B (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201261724781P 2012-11-09 2012-11-09
US13/679,245 US8545878B1 (en) 2012-11-09 2012-11-16 Capsules containing high doses of levodopa for pulmonary use
US13/945,160 US8685442B1 (en) 2012-11-09 2013-07-18 Capsules containing high doses of levodopa for pulmonary use
US201361884319P 2013-09-30 2013-09-30
US201361884315P 2013-09-30 2013-09-30
US201361884436P 2013-09-30 2013-09-30
PCT/US2013/069107 WO2014074797A1 (en) 2012-11-09 2013-11-06 Ultra low density pulmonary powders

Publications (1)

Publication Number Publication Date
ZA201504060B true ZA201504060B (en) 2016-04-28

Family

ID=50685169

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA2015/04060A ZA201504060B (en) 2012-11-09 2015-06-05 Ultra low density pulmonary powders
ZA2015/04058A ZA201504058B (en) 2012-11-09 2015-06-05 High dose levodopa capsules for pulmonary use

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA2015/04058A ZA201504058B (en) 2012-11-09 2015-06-05 High dose levodopa capsules for pulmonary use

Country Status (19)

Country Link
US (3) US9539211B2 (enExample)
EP (5) EP2925611B1 (enExample)
JP (6) JP6347786B2 (enExample)
KR (7) KR20230116102A (enExample)
CN (4) CN109106697B (enExample)
AU (6) AU2013342248B2 (enExample)
BR (2) BR112015010601B1 (enExample)
CA (3) CA2890451C (enExample)
DK (1) DK2916821T3 (enExample)
ES (2) ES2844153T3 (enExample)
HK (1) HK1212884A1 (enExample)
MX (4) MX377602B (enExample)
NZ (4) NZ733459A (enExample)
PL (1) PL2916821T3 (enExample)
PT (1) PT2916821T (enExample)
RU (2) RU2670987C2 (enExample)
SG (5) SG11201503547TA (enExample)
WO (3) WO2014074797A1 (enExample)
ZA (2) ZA201504060B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1212623A1 (zh) 2012-10-22 2016-06-17 丝维塔斯治疗公司 用於快速緩解帕金森病的左旋多巴製劑
BR112015010601B1 (pt) * 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
MA40910A (fr) * 2014-11-07 2017-09-12 Civitas Therapeutics Inc Poudres de rapamycine pour administration pulmonaire
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
CN108700448B (zh) * 2016-02-06 2020-08-04 德国翰辉包装机械有限责任公司 刺戳吸移管
ITUA20163077A1 (it) * 2016-05-02 2017-11-02 Mg 2 Srl Gruppo di alimentazione per il dosaggio di granuli, in particolare microgranuli, in capsule
GB2550961A (en) * 2016-06-03 2017-12-06 Res Center Pharmaceutical Engineering Gmbh Apparatus for dosing a solid material into at least one receptacle
CN106394953A (zh) * 2016-06-24 2017-02-15 湖南千山制药机械股份有限公司 真空灌装系统
WO2019060797A1 (en) 2017-09-22 2019-03-28 Teva Branded Pharmaceutical Products R&D, Inc. PROCESS FOR PRODUCING POWDERS FOR INHALING
WO2019067708A1 (en) 2017-09-27 2019-04-04 Teva Branded Pharmaceutical Products R&D, Inc. METHOD FOR DECREASING PARTICLE SIZE
PT3833964T (pt) 2018-08-07 2023-08-17 Norton Waterford Ltd Aplicação de espetroscopia de raman para o fabrico de pós de inalação
EP3608015B1 (de) * 2018-08-08 2021-10-06 Harro Höfliger Verpackungsmaschinen GmbH Pulverbereitstellungseinrichtung für einen pulverdosierer
CN108995838A (zh) * 2018-09-10 2018-12-14 江西克莱威纳米碳材料有限公司 一种粉体装罐系统
CN109178367B (zh) * 2018-10-15 2021-01-26 楚天科技股份有限公司 用于粉体分装的灌装头和灌装装置
CN110040519B (zh) * 2019-04-30 2024-12-24 裕东（中山）机械工程有限公司 一种定量气固两相流输送装置及定量输送系统
EP3756640A1 (en) 2019-06-26 2020-12-30 Fette Compacting GmbH System and method for continuous production of solid dosage forms
RU2716294C1 (ru) * 2019-10-04 2020-03-11 Владимир Александрович Трусов Двухванная отражательная печь для переплава алюминиевого лома
JP2023526763A (ja) * 2020-04-22 2023-06-23 キャプシュゲル・ベルジウム・エヌ・ヴィ 低減した粉末滞留を有するｈｐｍｃカプセル
IT202000008962A1 (it) * 2020-04-24 2021-10-24 Romaco Srl Apparecchiatura per il riempimento di contenitori con un materiale in polvere
WO2022122012A1 (zh) * 2020-12-11 2022-06-16 江苏恒瑞医药股份有限公司 用于肺部递送的药物组合物
EP4201390A1 (de) * 2021-12-21 2023-06-28 Harro Höfliger Verpackungsmaschinen GmbH Kapselfüllmaschine zur befüllung zweiteiliger kapseln und verfahren zur befüllung zweiteiliger kapseln
EP4220101A1 (de) * 2022-01-26 2023-08-02 Harro Höfliger Verpackungsmaschinen GmbH Fülleinrichtung und füllsystem zum volumetrischen dosieren von pulver

Family Cites Families (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2540059A (en) * 1947-08-02 1951-01-30 American Cyanamid Co Method of and apparatus for measuring and filling powders volumetrically
US3656518A (en) * 1967-03-27 1972-04-18 Perry Ind Inc Method and apparatus for measuring and dispensing predetermined equal amounts of powdered material
US3847191A (en) * 1971-08-23 1974-11-12 T Aronson Means and methods for measuring and dispensing equal amounts of powdered material
IT1069354B (it) * 1976-03-05 1985-03-25 Zanasi Nigris Spa Perfezionamenti nei dosatori volume trici
IT1156553B (it) * 1982-03-03 1987-02-04 Mg 2 Spa Procedimento per prelevare una quantita' prefissata di polvere dall'interno di un recipiente rotante e per depositare tale quantita' all'interno di un fondello di un contenitore di forma qualsiasi e macchina ch attui tale procedimento
JPS59115201A (ja) * 1982-12-10 1984-07-03 武田薬品工業株式会社 粉粒体処理機における粉粒体のシール装置
JPS63289922A (ja) * 1987-05-22 1988-11-28 Toshiba Corp 減圧気相成長装置
IT1245757B (it) * 1991-01-15 1994-10-14 Mg 2 Spa Macchina per il dosaggio di prodotti farmaceutici in polvere.
US5111642A (en) * 1991-01-23 1992-05-12 Macofar S.P.A. Machine for the dosage of powders in capsules, in particular for the pharmaceutical industry
US5756123A (en) 1994-12-01 1998-05-26 Japan Elanco Co., Ltd. Capsule shell
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
EP0896525B1 (en) * 1996-04-29 2003-08-27 Dura Pharmaceuticals, Inc. Methods of dry powder inhalation
US5985309A (en) 1996-05-24 1999-11-16 Massachusetts Institute Of Technology Preparation of particles for inhalation
US20020052310A1 (en) 1997-09-15 2002-05-02 Massachusetts Institute Of Technology The Penn State Research Foundation Particles for inhalation having sustained release properties
US6503480B1 (en) 1997-05-23 2003-01-07 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5874064A (en) 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US6652837B1 (en) * 1996-05-24 2003-11-25 Massachusetts Institute Of Technology Preparation of novel particles for inhalation
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
USRE37053E1 (en) 1996-05-24 2001-02-13 Massachusetts Institute Of Technology Particles incorporating surfactants for pulmonary drug delivery
US6254854B1 (en) 1996-05-24 2001-07-03 The Penn Research Foundation Porous particles for deep lung delivery
WO1998029098A1 (en) * 1996-12-31 1998-07-09 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
US7052678B2 (en) 1997-09-15 2006-05-30 Massachusetts Institute Of Technology Particles for inhalation having sustained release properties
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20040028735A1 (en) 1997-11-14 2004-02-12 Unchalee Kositprapa Pharmaceutical formulation
EP1069889B1 (de) * 1998-04-09 2004-06-30 Celanese Ventures GmbH Partikulärer wirkstoffträger für die pulmonale applikation
MA25590A1 (fr) * 1998-09-14 2002-12-31 Inhale Therapeutic Syst Agent actif de delivraison de poudre seche
IT1304779B1 (it) * 1998-12-03 2001-03-29 Ima Spa Dosatrice a disco ed a pestelli, a funzionamento intermittente,monogiostra, particolarmente adatta per il confezionamento di dosi
US6858199B1 (en) 2000-06-09 2005-02-22 Advanced Inhalation Research, Inc. High efficient delivery of a large therapeutic mass aerosol
US6586008B1 (en) 1999-08-25 2003-07-01 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles during spray drying
US7252840B1 (en) 1999-08-25 2007-08-07 Advanced Inhalation Research, Inc. Use of simple amino acids to form porous particles
GB9926335D0 (en) * 1999-11-05 2000-01-12 Powderject Res Ltd Apparatus and method for dispensing small quantities of particles
GB2356386A (en) 1999-11-17 2001-05-23 Tagra Biotechnologies Ltd Microencapsulation
US20030180352A1 (en) 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB0014082D0 (en) * 2000-06-10 2000-08-02 Glaxo Group Ltd Method and apparatus for transferring a defined quantity of powder
US6514482B1 (en) 2000-09-19 2003-02-04 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US6613308B2 (en) 2000-09-19 2003-09-02 Advanced Inhalation Research, Inc. Pulmonary delivery in treating disorders of the central nervous system
US20020122773A1 (en) * 2000-12-20 2002-09-05 Michel Pairet Pharmaceutical compositions based on anticholinergics and dopamine agonists
WO2002053190A2 (en) 2000-12-29 2002-07-11 Advanced Inhalation Research, Inc. Particles for inhalation having sustained release properties
US6766799B2 (en) 2001-04-16 2004-07-27 Advanced Inhalation Research, Inc. Inhalation device
US6848197B2 (en) 2001-04-18 2005-02-01 Advanced Inhalation Research, Inc. Control of process humidity to produce large, porous particles
JP4039950B2 (ja) * 2001-04-20 2008-01-30 グラクソ グループ リミテッド 粒子状物質の計量供給方法
JP2004538267A (ja) 2001-05-25 2004-12-24 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 閉塞性気道疾患及びその他の炎症性疾患を治療するためのドーパミンｄ２−受容体アゴニスト及びチオトロピウム又はその誘導体の組み合わせ
US6531153B2 (en) 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US6767200B2 (en) * 2001-09-28 2004-07-27 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US7182961B2 (en) 2001-11-20 2007-02-27 Advanced Inhalation Research, Inc. Particulate compositions for pulmonary delivery
US7008644B2 (en) 2002-03-20 2006-03-07 Advanced Inhalation Research, Inc. Method and apparatus for producing dry particles
ES2718455T3 (es) 2002-03-20 2019-07-02 Civitas Therapeutics Inc Formulaciones terapéuticas sostenidas inhalables
US7754242B2 (en) 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
WO2003080163A1 (en) 2002-03-20 2003-10-02 Advanced Inhalation Research, Inc. Puncturing means for use in an inhalation device
SI2630954T1 (sl) * 2002-03-20 2017-02-28 Civitas Therapeutics, Inc. Pulmonalno dovajanje za levodopo
US20110123574A1 (en) * 2002-03-20 2011-05-26 Alkermes, Inc. Inhalable sustained therapeutic formulations
CA2483687A1 (en) * 2002-05-13 2003-11-20 Alexza Molecular Delivery Corporation Delivery of drug amines through an inhalation route
US6941980B2 (en) * 2002-06-27 2005-09-13 Nektar Therapeutics Apparatus and method for filling a receptacle with powder
CA2484950C (en) * 2002-06-27 2011-05-24 Nektar Therapeutics Device and method for controlling the flow of a powder
HUE033319T2 (en) 2002-06-28 2017-11-28 Civitas Therapeutics Inc Inhalation epinephrine
ITBO20020525A1 (it) * 2002-08-08 2004-02-09 Ima Spa Macchina opercolatrice.
ATE536930T1 (de) * 2002-11-26 2011-12-15 Univ Gent Verfahren und vorrichtung zur feuchtgranulierung von pulver
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
EP1617820B1 (en) * 2003-04-14 2018-03-21 Vectura Limited Dry power inhaler devices and dry power formulations for enhancing dosing efficiency
US7134459B2 (en) * 2003-06-12 2006-11-14 Symyx Technologies, Inc. Methods and apparatus for mixing powdered samples
DE20309279U1 (de) * 2003-06-12 2004-10-21 Harro Höfliger Verpackungsmaschinen GmbH Filterkolbenvorrichtung zum Abfüllen von pulvrigem Schüttgut
CA2528064C (en) 2003-06-13 2010-01-12 Advanced Inhalation Research, Inc. Low dose pharmaceutical powders for inhalation
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
EP3238708A1 (en) * 2003-12-31 2017-11-01 CyDex Pharmaceuticals, Inc. Inhalant formulation containing cyclodextrin and corticosteroid
SE0401842D0 (sv) * 2004-07-12 2004-07-12 Dizlin Medical Design Ab Infusion and injection solution of levodopa
GB0425758D0 (en) * 2004-11-23 2004-12-22 Vectura Ltd Preparation of pharmaceutical compositions
US20060216345A1 (en) 2005-03-24 2006-09-28 Sun Pharmaceutical Industries Limited Oral pharmaceutical composition including paroxetine
US20060222699A1 (en) 2005-03-29 2006-10-05 Jonathan Gilinski Flavored vegetarian cellulose capsule and methods for producing said capsule.
AR055106A1 (es) 2005-08-05 2007-08-08 Osmotica Pharmaceutical Argent Composicion farmaceutica solida de liberacion extendida que contiene carbidopa y levodopa
CN101243130B (zh) * 2005-08-05 2011-12-07 3M创新有限公司 显示具有改善的流动性的组合物
DE102005039765A1 (de) * 2005-08-23 2007-03-01 Robert Bosch Gmbh Sensiervorrichtung
GB0523576D0 (en) * 2005-11-18 2005-12-28 Theradeas Ltd Drug composition and its use in therapy
WO2007092088A1 (en) * 2005-12-28 2007-08-16 Nektar Therapeutics Compositions comprising amphotericin b
DE602005020334D1 (de) * 2005-12-29 2010-05-12 Mg2 Srl Vorrichtung zum Befüllen von Kapseln mit einem Produkt
JP5457830B2 (ja) * 2006-04-03 2014-04-02 オディディ，イサ オルガノゾル被膜を含む制御放出送達デバイス
US20080063722A1 (en) 2006-09-08 2008-03-13 Advanced Inhalation Research, Inc. Composition of a Spray-Dried Powder for Pulmonary Delivery of a Long Acting Neuraminidase Inhibitor (LANI)
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
JP5372761B2 (ja) 2006-10-27 2013-12-18 ファイザー・プロダクツ・インク ヒドロキシプロピルメチルセルロース硬カプセルおよび製造方法
US20100316712A1 (en) 2006-12-22 2010-12-16 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
EP2155167A2 (en) 2007-06-04 2010-02-24 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
WO2008156586A2 (en) 2007-06-12 2008-12-24 Alkermes, Inc. Inhalation device for powdered substances
UY31235A1 (es) * 2007-07-21 2009-03-02 Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente
US8614255B2 (en) 2007-08-21 2013-12-24 Civitas Therapeutics, Inc. Pulmonary pharmaceutical formulations
GB2454480A (en) 2007-11-07 2009-05-13 Vectura Group Plc Pulmonary inhalation of levodopa containing compositions in the treatment of Parkinsons disease and other central nervous system disorders
SG10201507036TA (en) * 2008-06-13 2015-10-29 Mannkind Corp A dry powder inhaler and system for drug delivery
MX2010013731A (es) 2008-06-13 2011-01-14 Glaxo Group Ltd Cubierta de capsula de hidroxipropil celulosa.
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
WO2010035273A2 (en) 2008-09-29 2010-04-01 Intec Pharma Ltd. Novel gastroretentive delivery system
IT1390803B1 (it) * 2008-09-30 2011-10-19 Mg2 Srl Apparecchiatura per la dosatura di materiali pulverulenti o granulari in capsule o similari
US8399513B2 (en) 2008-10-20 2013-03-19 Xenoport, Inc. Levodopa prodrug mesylate hydrate
JP2012509922A (ja) * 2008-11-27 2012-04-26 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規粉末化結晶質吸入薬
ES2625260T5 (es) * 2009-03-26 2020-07-29 Pulmatrix Operating Co Inc Formulaciones de polvo seco y métodos para el tratamiento de enfermedades pulmonares
EA201171282A1 (ru) * 2009-04-24 2012-05-30 Айсьютика Пти Лтд. Способ производства коммерческих порошков, содержащих нано- и микрочастицы
IT1394027B1 (it) * 2009-05-11 2012-05-25 Mg 2 Srl Macchina per il riempimento di capsule con prodotti farmaceutici
US8359815B2 (en) * 2009-05-11 2013-01-29 Mg 2—S.R.L. Machine for filling capsules with pharmaceutical products
GB0918450D0 (en) * 2009-10-21 2009-12-09 Innovata Ltd Composition
RU2445119C2 (ru) * 2010-05-25 2012-03-20 Сергей Викторович Чепур Фармацевтическая композиция и способ ее ингаляционного введения
US20120164233A1 (en) 2010-07-30 2012-06-28 Ranbaxy Laboratories Limited Pulsatile release pharmaceutical formulation of dexlansoprazole
CN103200938B (zh) * 2010-08-30 2018-07-31 普马特里克斯营业公司 干燥粉末配方及用于治疗肺部疾病的方法
TW201304822A (zh) 2010-11-15 2013-02-01 Vectura Ltd 組成物及用途
HK1212623A1 (zh) 2012-10-22 2016-06-17 丝维塔斯治疗公司 用於快速緩解帕金森病的左旋多巴製劑
EP2908804A4 (en) 2012-10-22 2016-07-13 Civitas Therapeutics Inc REDUCTION OF VARIABILITY BETWEEN PATIENTS OF LEVODOPA PLASMA CONCENTRATIONS
BR112015010601B1 (pt) 2012-11-09 2022-07-19 Civitas Therapeutics, Inc. Composição farmacêutica e uso da composição
US8545878B1 (en) 2012-11-09 2013-10-01 Civitas Therapeutics, Inc. Capsules containing high doses of levodopa for pulmonary use
WO2015163840A1 (en) 2014-04-21 2015-10-29 Civitas Therapeutics, Inc. Rapid relief of motor fluctuations in parkinson's disease

Also Published As

Publication number Publication date
SG11201503547TA (en) 2015-06-29
AU2013342248B2 (en) 2018-05-31
EP3815679A1 (en) 2021-05-05
JP6836834B2 (ja) 2021-03-03
AU2013342246A1 (en) 2015-07-02
HK1213187A1 (en) 2016-06-30
CA2890459A1 (en) 2014-05-15
DK2916821T3 (da) 2021-01-18
JP6669808B2 (ja) 2020-03-18
AU2013342247B2 (en) 2017-09-21
HK1213535A1 (en) 2016-07-08
US9642812B2 (en) 2017-05-09
WO2014074797A8 (en) 2014-06-26
AU2013342247C1 (en) 2017-12-21
HK1213186A1 (en) 2016-06-30
RU2670987C2 (ru) 2018-10-29
CN109106697A (zh) 2019-01-01
CN104918607B (zh) 2018-10-12
CN104918607A (zh) 2015-09-16
BR112015010601A8 (pt) 2018-01-16
CN110833539A (zh) 2020-02-25
AU2017279626A1 (en) 2018-01-18
JP6721629B2 (ja) 2020-07-15
EP2916821B1 (en) 2020-10-21
KR20210152020A (ko) 2021-12-14
KR20210062730A (ko) 2021-05-31
MX382999B (es) 2025-03-13
EP2916821A4 (en) 2016-08-03
KR102389785B1 (ko) 2022-04-22
SG10201706465XA (en) 2017-09-28
KR20240134230A (ko) 2024-09-06
JP2015536988A (ja) 2015-12-24
MX2015005768A (es) 2015-11-25
US20150342890A1 (en) 2015-12-03
SG10202109328QA (en) 2021-10-28
CA2890454C (en) 2020-10-27
AU2018222983B2 (en) 2020-02-27
AU2018204674B2 (en) 2019-09-19
SG10201707103SA (en) 2017-10-30
CA2890451A1 (en) 2014-05-15
BR112015010603B1 (pt) 2022-10-11
AU2017279626B2 (en) 2019-09-12
PT2916821T (pt) 2021-01-21
KR20220054703A (ko) 2022-05-03
EP3957301A1 (en) 2022-02-23
ES2880271T3 (es) 2021-11-24
AU2013342248A1 (en) 2015-07-02
NZ708682A (en) 2017-11-24
EP2925611A4 (en) 2016-09-07
NZ733459A (en) 2019-09-27
EP2925611A1 (en) 2015-10-07
JP2018162258A (ja) 2018-10-18
US20150342885A1 (en) 2015-12-03
BR112015010603A2 (pt) 2017-08-15
CN105120843A (zh) 2015-12-02
EP2916826A1 (en) 2015-09-16
AU2018204674A1 (en) 2018-07-12
WO2014074795A1 (en) 2014-05-15
EP2916821A1 (en) 2015-09-16
EP2916826B1 (en) 2021-04-28
NZ747376A (en) 2020-02-28
CA2890454A1 (en) 2014-05-15
AU2013342247A1 (en) 2015-07-02
MX377602B (es) 2025-03-10
KR102735396B1 (ko) 2024-11-27
AU2018222983A1 (en) 2018-09-20
BR112015010601B1 (pt) 2022-07-19
EP2925611B1 (en) 2022-03-09
NZ708684A (en) 2019-09-27
US10238607B2 (en) 2019-03-26
ES2844153T3 (es) 2021-07-21
EP2916826A4 (en) 2016-07-27
RU2676093C2 (ru) 2018-12-26
CA2890459C (en) 2022-08-23
KR20150110480A (ko) 2015-10-02
JP2015536197A (ja) 2015-12-21
WO2014074796A1 (en) 2014-05-15
CN109106697B (zh) 2022-02-15
RU2015121091A (ru) 2017-01-10
JP2018150355A (ja) 2018-09-27
MX2020012506A (es) 2021-02-15
JP6347786B2 (ja) 2018-06-27
KR20230116102A (ko) 2023-08-03
US9539211B2 (en) 2017-01-10
WO2014074797A1 (en) 2014-05-15
KR102337781B1 (ko) 2021-12-09
MX2015005767A (es) 2015-11-25
KR20150108816A (ko) 2015-09-30
HK1214957A1 (zh) 2016-08-12
JP2015536989A (ja) 2015-12-24
SG11201503543PA (en) 2015-06-29
BR112015010601A2 (enExample) 2017-08-15
KR102257164B1 (ko) 2021-05-26
ZA201504058B (en) 2016-11-30
JP6348501B2 (ja) 2018-06-27
AU2013342246B2 (en) 2018-03-29
RU2015121092A (ru) 2017-01-10
CA2890451C (en) 2022-07-19
PL2916821T3 (pl) 2021-07-05
JP2019213867A (ja) 2019-12-19
HK1212884A1 (zh) 2016-06-24
MX371008B (es) 2020-01-13
US20180036253A1 (en) 2018-02-08

Similar Documents

Publication Publication Date Title
ZA201504060B (en) Ultra low density pulmonary powders
SG11201502567TA (en) Sintering powder
PL2914359T3 (pl) Separator magnetyczny
PL2797613T3 (pl) Wektory kodujące pręcikowy czynnik żywotności czopków
EP2812944A4 (en) SUPRALUMINIC ANTENNA
IL236330A0 (en) Characterization of particles
GB2505764B (en) Improvements in dielectrics
EP2941689A4 (en) REACTIVE ADVERTISING FORMATS
HUP1200534A3 (en) Coaxial loudspeker arrangemet
PL2669361T3 (pl) Suszony rozpyłowo detergent proszkowy
EP2928018A4 (en) ANTENNA
IL218691A0 (en) Aqua based super capacitor
GB201216930D0 (en) Nanoparticles
GB201210816D0 (en) Balun
GB2510575B (en) Parcel depositary
EP2867303A4 (en) PARTICLES OF THE SILSESQUIOXANE TYPE
GB201216538D0 (en) Magnetic structures
GB201209517D0 (en) Nanoparticles
GB201704907D0 (en) Storage
GB201317652D0 (en) Magnetic separator
GB2502547B (en) Cart
GB2499450B (en) Magnetic toy
PL2650192T3 (pl) Wózek transportowy
GB201221038D0 (en) Antenna
IL236367A0 (en) particle size reduction